S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
S&P 500   3,114.99 (+0.07%)
DOW   27,665.24 (+0.06%)
QQQ   202.62 (+0.09%)
AAPL   265.23 (+1.33%)
FB   199.05 (+0.17%)
MSFT   150.00 (+0.10%)
GOOGL   1,325.10 (+0.47%)
AMZN   1,748.82 (-0.67%)
NVDA   208.75 (-0.32%)
MU   46.43 (+0.26%)
BABA   199.87 (+3.16%)
TSLA   331.47 (-0.47%)
T   38.32 (+0.55%)
AMD   39.73 (+0.10%)
ACB   2.44 (-1.61%)
F   8.91 (-0.45%)
NFLX   300.68 (-1.20%)
BAC   33.12 (-0.09%)
Log in

NeuBase Therapeutics News Headlines (NASDAQ:NBSE)

$7.03
+0.17 (+2.48 %)
(As of 12/5/2019 02:20 PM ET)
Today's Range
$6.94
Now: $7.03
$7.15
50-Day Range
$4.46
MA: $5.41
$7.17
52-Week Range
$1.60
Now: $7.03
$7.39
Volume3,308 shs
Average Volume150,429 shs
Market Capitalization$120.00 million
P/E RatioN/A
Dividend YieldN/A
Beta1.02

Headlines

NeuBase Therapeutics (NASDAQ NBSE) News Headlines

Source:
DateHeadline
Critical Survey: NeuBase Therapeutics (NASDAQ:NBSE) & Alder Biopharmaceuticals (NASDAQ:ALDR)Critical Survey: NeuBase Therapeutics (NASDAQ:NBSE) & Alder Biopharmaceuticals (NASDAQ:ALDR)
www.americanbankingnews.com - December 2 at 8:53 AM
NeuBase Therapeutics (NBSE) Buy Rating Reiterated at HC WainwrightNeuBase Therapeutics' (NBSE) Buy Rating Reiterated at HC Wainwright
www.americanbankingnews.com - December 2 at 7:43 AM
Zacks: Brokerages Expect NeuBase Therapeutics (NASDAQ:NBSE) Will Announce Earnings of -$0.24 Per ShareZacks: Brokerages Expect NeuBase Therapeutics (NASDAQ:NBSE) Will Announce Earnings of -$0.24 Per Share
www.americanbankingnews.com - December 2 at 4:24 AM
NeuBase Therapeutics (NASDAQ:NBSE) Short Interest UpdateNeuBase Therapeutics (NASDAQ:NBSE) Short Interest Update
www.americanbankingnews.com - November 27 at 12:38 PM
NeuBase Therapeutics, Inc. Common Stock (NBSE) Earnings Report DateNeuBase Therapeutics, Inc. Common Stock (NBSE) Earnings Report Date
www.nasdaq.com - November 27 at 8:07 AM
NeuBase Therapeutics to Present at Upcoming Investor Conferences in DecemberNeuBase Therapeutics to Present at Upcoming Investor Conferences in December
finance.yahoo.com - November 25 at 8:03 AM
Analysts Set Expectations for NeuBase Therapeutics FY2019 Earnings (NASDAQ:NBSE)Analysts Set Expectations for NeuBase Therapeutics' FY2019 Earnings (NASDAQ:NBSE)
www.americanbankingnews.com - November 25 at 1:21 AM
NeuBase Therapeutics, Inc. (NBSE): Hedge Funds Dropped The Ball?NeuBase Therapeutics, Inc. (NBSE): Hedge Funds Dropped The Ball?
finance.yahoo.com - November 24 at 7:07 PM
NeuBase Therapeutics (NASDAQ:NBSE) Research Coverage Started at OppenheimerNeuBase Therapeutics (NASDAQ:NBSE) Research Coverage Started at Oppenheimer
www.americanbankingnews.com - November 20 at 6:59 PM
NeuBase Therapeutics (NASDAQ:NBSE) Sees Significant Growth in Short InterestNeuBase Therapeutics (NASDAQ:NBSE) Sees Significant Growth in Short Interest
www.americanbankingnews.com - November 14 at 11:18 PM
Short Interest in NeuBase Therapeutics (NASDAQ:NBSE) Drops By 34.7%Short Interest in NeuBase Therapeutics (NASDAQ:NBSE) Drops By 34.7%
www.americanbankingnews.com - November 12 at 11:46 PM
NeuBase Therapeutics to Present at the Stifel 2019 Healthcare ConferenceNeuBase Therapeutics to Present at the Stifel 2019 Healthcare Conference
finance.yahoo.com - November 12 at 1:45 PM
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines ConferenceNeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
finance.yahoo.com - October 29 at 8:39 AM
NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory BoardNeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board
finance.yahoo.com - October 29 at 8:39 AM
NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL™ Enabled TherapiesNeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL™ Enabled Therapies
finance.yahoo.com - October 29 at 8:39 AM
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel